Savolitinib
Savolitinib (AZD-6094) is a potent, highly selective, and orally bioavailable c-Met inhibitor with IC50 s of 5 nM and 3 nM for c-Met and p-Met, respectively. Savolitinib (AZD-6094) selectively binds to and inhibits the activation of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways. Antineoplastic activity[1][2].
Product Specifications
CAS Number
1313725-88-0
Product Name Alternative
Volitinib; HMPL-504; AZD-6094
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Savolitinib.html
Purity
99.99
Solubility
DMSO : ≥ 20.83 mg/mL
Smiles
CN1N=CC(C2=CN=C3C(N([C@H](C4=CN5C(C=C4)=NC=C5)C)N=N3)=N2)=C1
Molecular Formula
C17H15N9
Molecular Weight
345.36
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human COL2α1 (Collagen Type II Alpha 1) ELISA Kit
Human COL2α1 (Collagen Type II Alpha 1) ELISA Kit
Human COL2α1 (Collagen Type II Alpha 1) ELISA Kit
Ki-67 (Proliferating Cell Marker) (MKI67/2466), CF488A conjugate, 0.1mg/mL
